QIM
TCRT icon

Quantitative Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Quantitative Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-152
Closed -$82K – 580
2021
Q1 		$82K Buy
+152
New +$94.6K 0.01% 468
2020
Q2 		– Sell
-587
Closed -$215K – 680
2020
Q1 		$215K Buy
587
+517
+739% +$268K 0.02% 440
2019
Q4 		$49K Sell
70
-1,155
-94% -$795K ﹤0.01% 607
2019
Q3 		$786K Buy
+1,225
New +$972K 0.04% 399
2017
Q2 		– Sell
-1,015
Closed -$965K – 881
2017
Q1 		$965K Sell
1,015
-1,070
-51% -$996K 0.01% 558
2016
Q4 		$1.67M Buy
+2,085
New +$1.88M 0.04% 525
2016
Q1 		– Sell
-621
Closed -$773K – 927
2015
Q4 		$773K Buy
+621
New +$1.03M 0.05% 409
2015
Q2 		– Sell
-855
Closed -$1.38M – 681
2015
Q1 		$1.38M Buy
+855
New +$1.27M 0.13% 141
2014
Q2 		– Sell
-180
Closed -$123K – 628
2014
Q1 		$123K Buy
+180
New +$121K 0.01% 497

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quantitative Investment Management's TCRT Position: Q2 2021 in Review

Quantitative Investment Management sold out of Alaunos Therapeutics (TCRT) in Q2 2021, closing a stake of 152 shares — an estimated $82K sold.

Quantitative Investment Management first reported a position in TCRT in Q1 2014 and held it in 9 quarters. The position peaked at $1.67M in Q4 2016. 155 funds tracked by Wall St. Rank hold TCRT as of Q2 2021.

  • Quantitative Investment Management reported no remaining Alaunos Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 152 Alaunos Therapeutics shares in Q2 2021, an estimated $82K.
  • Quantitative Investment Management first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 9 quarters.
  • Quantitative Investment Management's Alaunos Therapeutics position peaked at $1.67M in Q4 2016.
  • 155 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.